Vimarsana
Biggest News Aggregation in the World

Page 20 - Translational Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Translational Sciences Today - Breaking & Trending Today

Seizures identified as potential cause of sud - Vimarsana News

Seizures identified as potential cause of sud

<p>In a study designed to better understand sudden, unexpected deaths in young children, which usually occur during sleep, researchers have identified brief seizures, accompanied by muscle convulsions, as a potential cause.</p> <p>&nbsp;</p>

Calcium channel blockers reverse muscle weakness in animal model of myotonic dystrophy type 1 - Vimarsana News

Calcium channel blockers reverse muscle weakness in animal model of myotonic dystrophy type 1

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these symptoms in animal models of the disease.

Could Calcium Blockers Reverse Myotonic Dystrophy Weakness? - Vimarsana News

Could Calcium Blockers Reverse Myotonic Dystrophy Weakness?

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1).

Food allergies? Pesticides in tap water might be to blame - Vimarsana News

Food allergies? Pesticides in tap water might be to blame

Contact: Christine Westendorf christinewestendorf@acaai.org 847-427-1200 American College of Allergy, Asthma, and Immunology New study finds chemicals used for water purification can lead to food allergies ARLINGTON HEIGHTS, Ill. (December 3, 2012) – Food allergies are on the rise, affecting 15 million Americans. And according to a new study published in the December issue of Annals…

BU Researchers Helped Develop the First FDA-Approved Gene Therapies to Treat Sickle Cell Disease - Vimarsana News

BU Researchers Helped Develop the First FDA-Approved Gene Therapies to Treat Sickle Cell Disease

The first FDA-approved gene therapies for curing sickle cell disease can transform patients’ lives, according to the BU experts that helped create them.

Source: bu.edu